ZygoFix
Israel - MisgavBiotechnology
Focus: ZygoFix is an Israeli-headquartered medical device biotechnology company specializing in spinal fusion solutions, specifically the zLOCK Facet Stabilization System for low back pain management. As a publicly listed company founded in 2018, it operates in the musculoskeletal device space with a focused product portfolio.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
0
About ZygoFix
AI assessmentNot HiringNo open roles listed right now. Follow ZygoFix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
zLOCK Facet Stabilization System
Low Back PainClinical Trials (1)
NCT05266521Safety and Efficacy Assessment of Using the zLOCK Facet Stabilization System
N/AHelp build intelligence for ZygoFix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.